Camp - CAMP

La cadena de opciones muestra datos clave de las opciones de acciones de Camp4 Therapeutics a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Camp4 Therapeutics..

Camp4 Therapeutics (NASDAQ:CAMP) Bolsa, Cadena de Opciones

Camp4 Therapeutics

CalAmp

Camp4 Therapeutics Corp is a clinical stage biopharmaceutical company pioneering the discovery and development of regulatory RNA-based therapeutics to upregulate gene expression and restore healthy protein levels to treat various genetic diseases. It focuses on genetic diseases of the central nervous system and liver. The group's pipeline products are CMP-CPS-001 and CMP-SYNGAP.

CAMP4 Therapeutics Corporation - Common Stock

Camp4 Therapeutics Corp

CalAmp Corp

Campbell International Holding Corp

CAMPBELL RES INC by Campbell Resources Inc.

Campbell Resources Inc

Camping World Holdings, Inc. Class A Common Stock

Camping World Holdings Inc

CalAmp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAMP#NASDAQ">CAMP</a>) reported quarterly losses of $(11.04) per share which met the analyst consensus estimate. This is a 91.15 percent increase over losses of $(124.80) per share from the same period last year.

Earnings

News

CAMP

CalAmp FY 2024 GAAP EPS $(11.04), Inline

<h3>Gainers</h3>
<ul>
<li>Healthcare Triangle (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCTI#NASDAQ">HCTI</a>) shares increased by 81.7% to $0.87 during Tuesday's pre-market session. The company's market cap stands at $4.9 million. </li>
<li>GlycoMimetics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLYC#NASDAQ">GLYC</a>) stock rose 35.65% to $0.39. The company's market cap stands at $25.3 million. The company's, Q4 earnings came out 3 days ago. </li>
<li>Innate Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPHA#NASDAQ">IPHA</a>) shares rose 33.5% to $2.59. The market value of their outstanding shares is at $217.0 million. </li>
<li>Aditxt (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADTX#NASDAQ">ADTX</a>) shares moved upwards by 30.85% to $0.09. The market value of their outstanding shares is at $7.2 million. </li>
<li>GeneDx Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WGS#NASDAQ">WGS</a>) shares moved upwards by 18.0% to $90.1. The market value of their outstanding shares is at $2.4 billion. The company's, Q4 earnings came out today. </li>
<li>Camp4 Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAMP#NASDAQ">CAMP</a>) stock moved upwards by 17.25% to $5.98. The company's market cap stands at $120.5 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Reshape Lifesciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RSLS#NASDAQ">RSLS</a>) shares fell 57.1% to $1.0 during Tuesday's pre-market session. </li>
<li>Bio-Path Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BPTH#NASDAQ">BPTH</a>) shares fell 33.2% to $0.42. The market value of their outstanding shares is at $2.4 million. </li>
<li>Petros Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTPI#NASDAQ">PTPI</a>) shares decreased by 24.92% to $0.22. The company's market cap stands at $2.4 million. </li>
<li>Virpax Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRPX#NASDAQ">VRPX</a>) shares decreased by 16.8% to $0.27. The market value of their outstanding shares is at $4.9 million. </li>
<li>Moleculin Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBRX#NASDAQ">MBRX</a>) shares decreased by 15.6% to $1.84. The company's market cap stands at $6.2 million. </li>
<li>Omega Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OMGA#NASDAQ">OMGA</a>) stock declined by 14.8% to $0.2. The market value of their outstanding shares is at $10.8 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

ADTX

BPTH

GLYC

HCTI

IPHA

MBRX

OMGA

PTPI

RSLS

VRPX

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Expected Milestones in 2025
<ul>
<li>MAD safety, pharmacokinetic and key pharmacodynamic biomarker data in healthy volunteers in the second half of 2025.</li>
<li>GLP toxicity studies of lead ASO candidate for neurodevelopmental disorders caused by SYNGAP1 mutations to be initiated this year.</li>
<li>Advance a new discovery program targeting a GBA1 regRNA to increase gene expression for the treatment of Parkinson's disease (PD) caused by mutations in GBA1, with potential for application in sporadic PD.</li>
<li>Company to focus on expanding its strategic partnerships to continue maximizing the value of its RAP platform.</li>
</ul>

Biotech

General

CAMP4 Outlines 2025 Milestones: MAD Safety Data in H2, GLP Toxicity Studies for SYNGAP1 Disorders, New GBA1 Discovery for Parkinson's, and Strategic Partnership Expansion.

<h3>Gainers</h3>
<ul>
<li>Portage Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRTG#NASDAQ">PRTG</a>) shares increased by 178.2% to $9.04 during Tuesday's pre-market session. The company's market cap stands at $10.1 million. </li>
<li>Tonix Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TNXP#NASDAQ">TNXP</a>) shares moved upwards by 137.73% to $1.26. The market value of their outstanding shares is at $235.4 million. </li>
<li>Camp4 Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAMP#NASDAQ">CAMP</a>) shares rose 39.15% to $8.85. The company's market cap stands at $178.4 million. </li>
<li>Akari Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AKTX#NASDAQ">AKTX</a>) stock rose 27.53% to $1.26. The market value of their outstanding shares is at $33.3 million. </li>
<li>Teva Pharmaceutical Indus (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TEVA#NYSE">TEVA</a>) shares moved upwards by 19.13% to $19.67. The market value of their outstanding shares is at $22.2 billion. </li>
<li>Polyrizon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLRZ#NASDAQ">PLRZ</a>) stock rose 17.99% to $1.18. The market value of their outstanding shares is at $4.9 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Vaccinex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VCNX#NASDAQ">VCNX</a>) stock decreased by 47.7% to $1.91 during Tuesday's pre-market session. The market value of their outstanding shares is at $5.1 million. </li>
<li>Reviva Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RVPH#NASDAQ">RVPH</a>) shares decreased by 38.27% to $1.42. The company's market cap stands at $47.4 million. </li>
<li>PepGen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEPG#NASDAQ">PEPG</a>) shares decreased by 33.49% to $3.0. The market value of their outstanding shares is at $97.7 million. </li>
<li>Tenaya Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TNYA#NASDAQ">TNYA</a>) stock declined by 31.25% to $1.98. The company's market cap stands at $156.8 million. </li>
<li>LeMaitre Vascular (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LMAT#NASDAQ">LMAT</a>) stock declined by 23.79% to $70.19. The market value of their outstanding shares is at $1.5 billion. </li>
<li>Biomea Fusion (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BMEA#NASDAQ">BMEA</a>) shares decreased by 12.49% to $5.12. The company's market cap stands at $185.5 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AKTX

BMEA

LMAT

PEPG

PLRZ

PRTG

RVPH

TEVA

TNXP

TNYA

VCNX

<h3>Gainers</h3>
<ul>
<li>Universe Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPC#NASDAQ">UPC</a>) stock rose 192.4% to $3.07 during Friday's pre-market session. The market value of their outstanding shares is at $4.8 million. </li>
<li>VSee Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VSEE#NASDAQ">VSEE</a>) shares moved upwards by 25.17% to $1.84. The market value of their outstanding shares is at $28.8 million. </li>
<li>Radiopharm Theranostics Limited - American Depositary Shares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RADX#NASDAQ">RADX</a>) shares increased by 24.5% to $22.0. </li>
<li>Innate Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPHA#NASDAQ">IPHA</a>) shares increased by 17.23% to $1.7. The market value of their outstanding shares is at $137.6 million. </li>
<li>Sonoma Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNOA#NASDAQ">SNOA</a>) stock increased by 14.28% to $2.96. The market value of their outstanding shares is at $3.9 million. </li>
<li>Cardio Diagnostics Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDIO#NASDAQ">CDIO</a>) shares rose 14.12% to $0.53. The market value of their outstanding shares is at $21.4 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Bluejay Diagnostics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BJDX#NASDAQ">BJDX</a>) stock fell 25.3% to $4.63 during Friday's pre-market session. The market value of their outstanding shares is at $2.5 million. </li>
<li>Camp4 Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAMP#NASDAQ">CAMP</a>) stock declined by 18.35% to $8.01. The market value of their outstanding shares is at $161.4 million. </li>
<li>Molecular Templates (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTEM#NASDAQ">MTEM</a>) shares fell 14.76% to $0.46. The market value of their outstanding shares is at $3.0 million. </li>
<li>Psyence Biomedical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PBM#NASDAQ">PBM</a>) stock declined by 14.4% to $2.26. The company's market cap stands at $1.9 million. </li>
<li>Silexion Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLXN#NASDAQ">SLXN</a>) shares declined by 11.62% to $2.74. The market value of their outstanding shares is at $4.3 million. </li>
<li>Virpax Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRPX#NASDAQ">VRPX</a>) shares declined by 10.54% to $0.35. The market value of their outstanding shares is at $2.8 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BJDX

Cardio Diagnostics Holdings Inc. - Common stock

CDIO

MTEM

RADX

SLXN

SNOA

VSEE

12 Health Care Stocks Moving In Friday's Pre-Market Session

Shares of DocuSign, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOCU#NASDAQ">DOCU</a>) rose sharply in today's pre-market trading r after the company reported better-than-expected third-quarter financial results and issued FY25 revenue <a href="https://www.benzinga.com/news/earnings/24/12/42352653/docusign-stock-soars-on-q3-earnings-beat-revenue-beat-strong-guidance">guidance above estimates</a>.
DocuSign reported third-quarter revenue of $754.8 million, beating the consensus estimate of $745.26 million. The company reported third-quarter adjusted earnings of 90 cents per share, beating analyst estimates of 87 cents per share, according to Benzinga Pro.
DocuSign shares jumped 14.1% to $95.43 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Universe Pharmaceuticals INC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPC#NASDAQ">UPC</a>) gained 196.2% to $3.11 in pre-market trading after dipping 41% on Thursday.</li>
<li>Zhibao Technology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZBAO#NASDAQ">ZBAO</a>) rose 111.7% to $5.08 in pre-market trading after the company announced they will partner with PICC &amp; Munich Re to develop new medical insurance products in China.</li>
<li>Color Star Technology Co., Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADD#NASDAQ">ADD</a>) gained 82.2% to $6.94 in pre-market trading after the company announced that it regained Nasdaq compliance.</li>
<li>Gaxos.ai Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GXAI#NASDAQ">GXAI</a>) gained 48.6% to $2.11 in pre-market trading after gaining over 10% on Thursday.</li>
<li>The Lion Electric Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEV#NYSE">LEV</a>) gained 43.3% to $0.48 in pre-market trading. Lion Electric reached a definitive agreement in respect of the sale of Innovation Center located in Mirabel, Québec for a purchase price of C$50 million.</li>
<li>Primega Group Holdings Limited  (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PGHL#NASDAQ">PGHL</a>) rose 40.1% to $1.87 in pre-market trading after dipping over 15% on Thursday.</li>
<li>Rubrik, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBRK#NYSE">RBRK</a>) gained 23.2% to $66.11 in pre-market trading as the company reported better-than-expected results for its third quarter.</li>
<li>Asana, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASAN#NYSE">ASAN</a>) climbed 21.3% to $18.75 in pre-market trading after the company reported better-than-expected third-quarter financial results and issued FY25 guidance above estimates.</li>
<li>Satellogic Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SATL#NASDAQ">SATL</a>) gained 12.1% to $3.52 in pre-market trading after jumping 20% on Thursday.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Oriental Rise Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ORIS#NASDAQ">ORIS</a>) shares tumbled 81.23 to $10.50 in pre-market trading after surging 599% on Thursday.</li>
<li>zSpace, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZSPC#NASDAQ">ZSPC</a>) declined 31.7% to $15.01 in pre-market trading after jumping 340% on Thursday.</li>
<li>Foxx Development Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FOXX#NASDAQ">FOXX</a>) shares fell 24.7% to $3.73 in pre-market trading after jumping 55% on Thursday.</li>
<li>PainReform Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRFX#NASDAQ">PRFX</a>) shares fell 23.4% to $3.44 in pre-market trading. PainPerform shares jumped 68% on Thursday after the company announced changes in management including new CFO and CEO appointees.</li>
<li>Virpax Pharmaceuticals, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRPX#NASDAQ">VRPX</a>) fell 21.5% to $0.3069 in pre-market trading after declining around 5% on Thursday.</li>
<li>CAMP4 THERAPEUTICS CORPORATION (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAMP#NASDAQ">CAMP</a>) fell 21.4% to $7.71 in pre-market trading after gaining 66% on Thursday.</li>
<li>Protara Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TARA#NASDAQ">TARA</a>) fell 17.9% to $4.94 in pre-market trading. Protare Therapeutics shares jumped 70% on Thursday after the company announced results from its ongoing Phase 2 TARA-002 trial in patients with NMIBC.</li>
<li>Molecular Templates, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTEM#NASDAQ">MTEM</a>) dipped 17.1% to $0.4472 in pre-market trading after jumping 60% on Thursday.</li>
<li>Mawson Infrastructure Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MIGI#NASDAQ">MIGI</a>) shares dipped 16.7% to $1.10 in pre-market trading after jumping 94% on Thursday.</li>
<li>Smith &amp; Wesson Brands, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWBI#NASDAQ">SWBI</a>) fell 15.8% to $11.48 in today's pre-market trading after the company reported second-quarter results.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/24/12/42357598/dow-dips-more-than-200-points-ahead-of-jobs-report-investor-sentiment-declines-fear-greed-index-remains-in-greed-zone">Dow Takes A Breather After Record Close, Dips Over 200 Points Ahead Of Jobs Report: Fear Index Remains In &#8216;Greed&#8217; Zone</a></li>
</ul>

Pre-Market Outlook

Trading Ideas

ASAN

DOCU

FOXX

GXAI

MAWSON INFRSTRUCTURE GRP by Mawson Infrastructure Group Inc.

MIGI

ORIS

PGHL

PRFX

RBRK

SATL

SWBI

TARA

ZBAO

ZSPC

Why DocuSign Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket

CAMP4 Therapeutics Q3 EPS $(24.19), Ended Quarter With $2.5M In Cash And Cash Equivalents

In October, CAMP4 Therapeutics Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAMP#NASDAQ">CAMP</a>) priced its initial public offering of 6.82 million at $11.00 per share, with approximately $75 million <a href="https://www.benzinga.com/pressreleases/24/10/g41283554/camp4-announces-pricing-of-initial-public-offering" target="_blank" rel="noreferrer noopener">in gross proceeds</a>.
Camp4 is an RNA therapeutics company focused on developing therapies for rare diseases.
CAMP4 Therapeutics <a target="_blank" href="https://www.camp4tx.com/camp4-therapeutics-announces-dosing-of-first-participant-in-phase-1-clinical-study-of-cmp-cps-001-a-potential-first-in-class-therapeutic-for-urea-cycle-disorders/" rel="noreferrer noopener">dosed</a> the first participant in its Phase 1 study of CMP-CPS-001 for urea cycle disorders (UCDs) in March.
CMP-CPS-001 has secured FDA <a target="_blank" href="https://www.camp4tx.com/camp4-therapeutics-secures-orphan-drug-designation-for-cmp-cps-001-for-the-treatment-of-urea-cycle-disorders/" rel="noreferrer noopener">Orphan</a> Drug and Rare Pediatric <a target="_blank" href="https://www.camp4tx.com/camp4-therapeutics-secures-rare-pediatric-disease-designation-for-cmp-cps-001-for-the-treatment-of-urea-cycle-disorders/" rel="noreferrer noopener">Disease </a>Designations for urea cycle disorders.
Last month, the company announced a <a target="_blank" href="https://www.camp4tx.com/camp4-enters-strategic-research-collaboration-to-advance-novel-regulatory-rna-targeting-medicines-for-rare-genetic-conditions/" rel="noreferrer noopener">new</a> research collaboration with BioMarin Pharmaceutical Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BMRN#NASDAQ">BMRN</a>) to advance novel therapeutics that increase protein levels by targeting regulatory RNA (regRNA) sequences, key elements controlling gene expression.
Under the terms of the agreement, BioMarin has the right to select two targets identified by CAMP4's RAP Platform to advance into clinical development.
William Blair initiated coverage on CAMP4 Therapeutics, noting that Camp4&#8217;s shares trade at a significantly lower market cap than other early-stage genetic medicine companies, even though it has the innovative RAP platform. This unique platform offers a novel approach to enhancing target gene expression for rare diseases.
Piper Sandler initiated coverage on CAMP4 Therapeutics, noting that regRNAs could be the next big RNA modality with advantages over protein replacement or gene therapy.
The Piper analyst writes that any increase in ureagenesis rate test (URT) would be a signal of on-target CMP-CPS-001 ammonia lowering and provide proof-of-concept for urea cycle disorders patients.
The analyst expects CAMP4 to conduct registrational Phase 2 studies in urea cycle disorders patients and could gain FDA approval in 2029 with peak CMP-CPS-001 revenues of $1.0 billion by 2036.
Piper has initiated coverage of CAMP4 with an Overweight rating and a <a target="_blank" href="https://www.benzinga.com/quote/CAMP/analyst-ratings" rel="noreferrer noopener">price target of $18</a>.
Price Action: CAMP stock is up 13.5% at $9.33 at last check Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/24/11/41753070/alibaba-brings-singles-day-shopping-extravaganza-to-us-with-big-discounts" target="_blank" rel="noreferrer noopener">Alibaba Brings Singles&#8217; Day Shopping Extravaganza to US with Big Discounts</a></li>
</ul>
Image created using artificial intelligence via Midjourney.

Analyst Color

Health Care

Initiation

Analyst Ratings

BMRN

CAMP4 Analyst Highlights Rare Disease Platform Potential

WIIM

CAMP4 Therapeutics shares are trading higher after multiple firms initiated coverage on the stock with Overweight ratings.

William Blair analyst Myles Minter initiates coverage on Camp4 Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAMP#NASDAQ">CAMP</a>) with a Outperform rating.

William Blair Initiates Coverage On Camp4 Therapeutics with Outperform Rating

Leerink Partners analyst Mani Foroohar initiates coverage on Camp4 Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAMP#NASDAQ">CAMP</a>) with a Outperform rating and announces Price Target of $17.

Price Target

Leerink Partners Initiates Coverage On Camp4 Therapeutics with Outperform Rating, Announces Price Target of $17

JP Morgan analyst Eric Joseph initiates coverage on Camp4 Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAMP#NASDAQ">CAMP</a>) with a Overweight rating and announces Price Target of $23.

JP Morgan Initiates Coverage On Camp4 Therapeutics with Overweight Rating, Announces Price Target of $23

Piper Sandler analyst Edward Tenthoff initiates coverage on Camp4 Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAMP#NASDAQ">CAMP</a>) with a Overweight rating and announces Price Target of $18.

Piper Sandler Initiates Coverage On Camp4 Therapeutics with Overweight Rating, Announces Price Target of $18

IPOs

Camp4 Therapeutics Shares Open For Trade At $11.16/Share; IPO Priced At $11/Share On 6.82M Shares

Trading Halt: Halt status updated at 9:50:00 AM ET: Quotation Resumption: IPO Security - Released for Quotation

CAMP4 Therapeutics Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAMP#NASDAQ">CAMP</a>) IPO will take place October, 11 on the NASDAQ exchange under the ticker CAMP.
The company is offering shares at an expected price between $14.00 and $16.00 per share with an insider lock-up period of 180 days ending on April 09, 2025.
See also: <a href="https://www.benzinga.com/calendars/ipos">Benzinga IPO Calendar</a>
<h3>About CAMP4 Therapeutics Corporation</h3>
CAMP4 Therapeutics Corporation is a clinical-stage biopharmaceutical company pioneering the discovery and development of regulatory RNA-based therapeutics with the goal of upregulating gene expression and restoring healthy protein levels to treat a broad range of genetic diseases.
See also: <a href="https://www.benzinga.com/short-interest">Benzinga's Most Shorted Stocks</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Preview: Camp4 Therapeutics Corporation Set To IPO Tomorrow

<h3>Gainers</h3>
<ul>
<li>FOXO Technologies (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/FOXO#AMEX">FOXO</a>) stock increased by 21.8% to $0.33 during Tuesday's after-market session. The market value of their outstanding shares is at $3.5 million. </li>
<li>Oracle (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>) stock moved upwards by 8.02% to $133.82. The company's market cap stands at $367.8 billion. As per the press release, Q4 earnings came out today. </li>
<li>U-BX Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UBXG#NASDAQ">UBXG</a>) stock rose 7.57% to $12.5. The market value of their outstanding shares is at $337.5 million. </li>
<li>EMCORE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EMKR#NASDAQ">EMKR</a>) shares moved upwards by 7.27% to $0.87. The company's market cap stands at $7.2 million. </li>
<li>Rubrik (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBRK#NYSE">RBRK</a>) shares rose 5.64% to $37.25. The company's market cap stands at $6.5 billion. As per the news, the Q1 earnings report came out today. </li>
<li>CalAmp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAMP#NASDAQ">CAMP</a>) shares moved upwards by 5.29% to $0.42. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Signing Day Sports (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SGN#AMEX">SGN</a>) stock fell 5.5% to $0.29 during Tuesday's after-market session. The company's market cap stands at $4.4 million. </li>
<li>AmpliTech Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMPG#NASDAQ">AMPG</a>) stock declined by 5.36% to $1.06. The company's market cap stands at $10.3 million. </li>
<li>SkyWater Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SKYT#NASDAQ">SKYT</a>) stock fell 4.9% to $7.97. The market value of their outstanding shares is at $377.3 million. </li>
<li>Quantum Computing (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QUBT#NASDAQ">QUBT</a>) shares fell 4.71% to $0.65. The company's market cap stands at $59.1 million. </li>
<li>Ondas Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONDS#NASDAQ">ONDS</a>) stock declined by 4.52% to $0.82. The company's market cap stands at $54.6 million. </li>
<li>ReAlpha Tech Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIRE#NASDAQ">AIRE</a>) shares fell 3.85% to $1.0. The company's market cap stands at $44.1 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AIRE

AMPG

EMKR

FOXO

ONDS

ORCL

QUBT

SKYT

UBXG

12 Information Technology Stocks Moving In Tuesday's After-Market Session

Shares of Contango Ore, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CTGO#NYSE">CTGO</a>) fell sharply during Tuesday's session after the company announced pricing of $15 million <a href="https://www.benzinga.com/quote/CTGO/news">underwritten public offering</a>.
Contango Ore shares dipped 18.4% to $20.34 on Tuesday.
Here are some other stocks moving in today&#8217;s mid-day session.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Trio Petroleum Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TPET#NYSE">TPET</a>) shares jumped 88.2% to $0.4254 after the company completed its first two exploratory wells.</li>
<li>Airship AI Holdings, Inc.  (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AISP#NASDAQ">AISP</a>) shares climbed 32.5% to $4.1599. Airship AI announced a six-figure sole-source contract award within the Department of Justice for Acropolis Enterprise Video and Data Management Platform.</li>
<li>Blue World Acquisition Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BWAQ#NASDAQ">BWAQ</a>) shares gained 30.3% to $9.20 after declining around 4% on Monday.</li>
<li>ShiftPixy, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PIXY#NASDAQ">PIXY</a>) climbed 29.8% to $1.8950.</li>
<li>Kaixin Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KXIN#NASDAQ">KXIN</a>) rose 26.5% to $0.1769 after gaining around 4% on Monday.</li>
<li>U-BX Technology Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UBXG#NASDAQ">UBXG</a>) jumped 24% to $11.88.</li>
<li>CuriosityStream Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CURI#NASDAQ">CURI</a>) rose 24% to $1.24 as the company announced a share repurchase plan.</li>
<li>Nauticus Robotics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KITT#NASDAQ">KITT</a>) gained 21.4% to $0.2802 after surging 49% on Monday.</li>
<li>E-Home Household Service Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EJH#NASDAQ">EJH</a>) rose 19.7% to $0.5270.</li>
<li>Calavo Growers, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CVGW#NASDAQ">CVGW</a>) rose 14.1% to $28.50 after the company reported second-quarter financial results.</li>
<li>Moving iMage Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MITQ#NASDAQ">MITQ</a>) shares rose 13.1% to $0.6645.</li>
<li>Shoals Technologies Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHLS#NASDAQ">SHLS</a>) rose 10% to $7.49 after the company authorized a share repurchase program of up to $150 million and entered into a $25 million accelerated share repurchase agreement with Jefferies.</li>
<li>Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRBP#NASDAQ">CRBP</a>) jumped 8.8% to $47.74. RBC Capital analyst Brian Abrahams maintained Corbus Pharmaceuticals with an Outperform and raised the price target from $77 to $82.</li>
<li>Lixiang Education Holding Co., Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LXEH#NASDAQ">LXEH</a>) gained 8.3% to $0.3670.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Big Tree Cloud Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DSY#NASDAQ">DSY</a>) dipped 37.1% to $6.78.</li>
<li>Target Hospitality Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TH#NASDAQ">TH</a>) shares fell 35.5% to $6.78 after the company announced that it received notice that the U.S. government intends to terminate the existing South Texas Family Residential Center services agreement with its migrant programming partner.</li>
<li>Greenwave Technology Solutions, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GWAV#NASDAQ">GWAV</a>) dipped 32% to $1.98. Greemwabe Technology Solutions recently announced that its downstream processing system generated record revenues in May, 2024 and reaffirmed its confidence in exceeding its revenue guidance.</li>
<li>Barnes &amp; Noble Education, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BNED#NYSE">BNED</a>) declined 29.7% to $0.0941. Barnes &amp; Noble Education announced leadership changes and reverse stock split.</li>
<li>Sify Technologies Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SIFY#NASDAQ">SIFY</a>) fell 25% to $0.44. Sify Technologies recently announced the voluntary delisting date of its ADS rights from Nasdaq.</li>
<li>CalAmp Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAMP#NASDAQ">CAMP</a>) dipped 23% to $0.5009.</li>
<li>CoreCivic, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CXW#NYSE">CXW</a>) shares fell 19.7% to $11.88 after the company announced that it received a notice from the U.S. Immigration and Customs Enforcement that the agency intends to terminate its inter-governmental service agreement for services at the South Texas Family Residential Center.</li>
<li>Vicarious Surgical Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBOT#NYSE">RBOT</a>) declined 19.5% to $0.2878 after the company announced a reverse stock split.</li>
<li>Velo3D, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VLD#NYSE">VLD</a>) fell 19% to $0.1151 after the company announced a 1-for-35 reverse stock split.</li>
<li>ProKidney Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PROK#NASDAQ">PROK</a>) shares fell 16.1% to $2.5350 after the company announced a proposed $125 million public offering of class A ordinary shares and concurrent registered direct offering.</li>
<li>ZIM Integrated Shipping Services Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZIM#NYSE">ZIM</a>) shares fell 14.9% to $17.48 after gaining 5% on Monday.</li>
<li>MIND Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MIND#NASDAQ">MIND</a>) dipped 13.6% to $4.8699 following weak quarterly sales.</li>
<li>Rapport Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RAPP#NASDAQ">RAPP</a>) fell 13.4% to $22.67.</li>
<li>Montana Technologies Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIRJ#NASDAQ">AIRJ</a>) fell 12.8% to $8.80.</li>
<li>Hut 8 Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HUT#NASDAQ">HUT</a>) fell 8.6% to $9.00</li>
<li>Hoth Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOTH#NASDAQ">HOTH</a>) shares fell 7.8% to $0.9225. Hoth Therapeutics shares fell around 12% on Monday after the company announced a joint development agreement with Wise Systems International to utilize the BioNeMo AI platform of Nvidia.</li>
<li>Array Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARRY#NASDAQ">ARRY</a>) fell 6.9% to $13.02. Array Technologies announced the departure of Chief Financial Officer.</li>
<li>CleanSpark, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLSK#NASDAQ">CLSK</a>) fell 6.6% to $14.66 amid a pullback in Bitcoin.</li>
<li>Yext, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YEXT#NYSE">YEXT</a>) shares declined 6.3% to $4.7208 after the company reported worse-than-expected first-quarter financial results, issued weak second-quarter guidance and announced it will acquire Hearsay Systems.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/news/24/06/39269848/alphabet-to-rally-over-28-here-are-10-top-analyst-forecasts-for-tuesday">Alphabet To Rally Over 28%? Here Are 10 Top Analyst Forecasts For Tuesday</a>

Intraday Update

Markets

AIRJ

AISP

ARRY

BNED

BWAQ

CLSK

CRBP

CTGO

CURI

CVGW

GWAV

HOTH

KITT

KXIN

LXEH

MIND

MITQ

PIXY

PROK

RAPP

RBOT

SHLS

SIFY

TPET

YEXT

Why Contango Ore Shares Are Trading Lower By 18%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

<h3>Gainers</h3>
<ul>
<li>U-BX Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UBXG#NASDAQ">UBXG</a>) stock increased by 61.4% to $15.3 during Tuesday's regular session. The market value of their outstanding shares is at $413.0 million. </li>
<li>Airship AI Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AISP#NASDAQ">AISP</a>) shares rose 47.13% to $4.62. The market value of their outstanding shares is at $106.9 million. </li>
<li>Mercurity Fintech Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MFH#NASDAQ">MFH</a>) stock rose 23.11% to $1.97. The market value of their outstanding shares is at $119.8 million. </li>
<li>Sonim Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SONM#NASDAQ">SONM</a>) stock increased by 16.77% to $0.64. The market value of their outstanding shares is at $30.0 million. </li>
<li>Quantum (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QMCO#NASDAQ">QMCO</a>) stock rose 13.21% to $0.49. The company's market cap stands at $46.7 million. </li>
<li>GCT Semiconductor Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GCTS#NYSE">GCTS</a>) stock moved upwards by 11.61% to $3.94. The company's market cap stands at $180.8 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>CalAmp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAMP#NASDAQ">CAMP</a>) stock decreased by 33.4% to $0.44 during Tuesday's regular session. </li>
<li>Spectaire Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPEC#NASDAQ">SPEC</a>) shares declined by 23.15% to $0.39. The company's market cap stands at $7.1 million. </li>
<li>Neonode (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEON#NASDAQ">NEON</a>) stock fell 18.33% to $2.01. The market value of their outstanding shares is at $30.8 million. </li>
<li>ARB IOT Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARBB#NASDAQ">ARBB</a>) stock decreased by 10.42% to $0.64. The company's market cap stands at $16.9 million. </li>
<li>Comtech Telecom (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMTL#NASDAQ">CMTL</a>) shares declined by 9.59% to $2.08. The market value of their outstanding shares is at $59.0 million. </li>
<li>Lantronix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LTRX#NASDAQ">LTRX</a>) stock fell 9.03% to $3.63. The market value of their outstanding shares is at $136.4 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ARBB

CMTL

GCTS

LTRX

NEON

QMCO

SONM

SPEC

12 Information Technology Stocks Moving In Tuesday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>TROOPS (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TROO#NASDAQ">TROO</a>) stock increased by 13.7% to $1.74 during Tuesday's pre-market session. The market value of their outstanding shares is at $176.7 million. </li>
<li>SMX (Security Matters) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMX#NASDAQ">SMX</a>) shares moved upwards by 8.54% to $0.16. The company's market cap stands at $6.1 million. </li>
<li>Red Cat Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RCAT#NASDAQ">RCAT</a>) shares increased by 8.47% to $0.96. The market value of their outstanding shares is at $71.3 million. </li>
<li>UTime (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTO#NASDAQ">WTO</a>) stock increased by 7.48% to $0.58. The company's market cap stands at $227.5 million. </li>
<li>Cyngn (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYN#NASDAQ">CYN</a>) shares increased by 7.35% to $0.11. The company's market cap stands at $15.0 million. </li>
<li>Valens Semiconductor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VLN#NYSE">VLN</a>) shares rose 6.56% to $3.41. The market value of their outstanding shares is at $358.7 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>CalAmp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAMP#NASDAQ">CAMP</a>) shares decreased by 16.7% to $0.55 during Tuesday's pre-market session. </li>
<li>Yext (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YEXT#NYSE">YEXT</a>) shares declined by 11.91% to $4.44. The market value of their outstanding shares is at $559.3 million. As per the news, the Q1 earnings report came out yesterday. </li>
<li>Presto Automation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRST#NASDAQ">PRST</a>) stock declined by 8.28% to $0.1. The company's market cap stands at $11.7 million. </li>
<li>Spectaire Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPEC#NASDAQ">SPEC</a>) shares declined by 7.33% to $0.47. The market value of their outstanding shares is at $8.6 million. </li>
<li>Gryphon Digital Mining (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRYP#NASDAQ">GRYP</a>) stock declined by 6.48% to $1.3. The market value of their outstanding shares is at $51.0 million. </li>
<li>Adtran Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADTN#NASDAQ">ADTN</a>) stock fell 6.35% to $4.72. The market value of their outstanding shares is at $373.4 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ADTN

GRYP

PRST

RCAT

TROO

12 Information Technology Stocks Moving In Tuesday's Pre-Market Session

Press Releases

CAMP4 Announces Pricing of Initial Public Offering

CAMP4 Reports Third Quarter 2024 Financial Results

CAMP4 to Participate in the Piper Sandler 36th Annual Healthcare Conference

Management

CAMP4 Appoints John Maraganore and Rachel Meyers as Strategic Advisors

CAMP4 Provides Corporate Updates and Highlights Key Upcoming Milestones

CAMP4 to Present at the 43rd Annual J.P. Morgan Healthcare Conference

CAMP4 to Participate in Upcoming Investor Conferences

CalAmp Synovia to Showcase Leading Student Transportation Solutions at STN East 2025

Comments

Camp4 Therapeutics

Camp4 Therapeutics (CAMP) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL